ArticleNPJ science of food2026
Composite dietary fiber alleviates obesity-induced skeletal muscle atrophy by regulating gut microbiota-derived short-chain fatty acids in mice.
Article in NPJ science of food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Myokine Signaling in Sarcopenia-Associated Chronic Musculoskeletal Pain: A Systematic Review of Inflammatory Mechanisms.International journal of molecular sciences · 2026Pooled it
- Reframing obesity through the gut microbiota: functional dysbiosis and metabolic disease.Current opinion in clinical nutrition and metabolic care · 2026Review
- Article
- Gut Microbiota-Mediated Mechanisms of Traditional Chinese Medicine in Obesity Management.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Review
- The role of hormonal and nutritional biomarkers in predicting immune checkpoint inhibitor efficacy: current limitations and future prospects.Frontiers in immunology · 2026Review
- Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Obesity-induced muscle atrophy is a major health issue, in which gut microbiota play a key role in regulating metabolism and muscle health. This study investigated how composite dietary fiber protects against muscle atrophy in mice fed a high-fat diet (HFD). After 24 weeks of obesity induction, mice were divided into two groups: one continued on the HFD, while the other received the HFD supplemented with composite dietary fiber for 8 weeks. Composite dietary fiber ameliorated HFD-induced metabolic dysregulation by reducing adipose accumulation and improving insulin resistance. Notably, composite dietary fiber preserved skeletal muscle mass and function and downregulated the expression of key proteolytic markers Atrogin-1 and MuRF-1. The intervention enriched beneficial gut microbiota, particularly Bifidobacterium and other short-chain fatty acid (SCFA)-producing taxa, and elevated SCFA levels in both the colon and serum, with butyric acid increasing by 123.8% and 19.4%, respectively. PICRUSt2 analysis demonstrated enhanced microbial pyruvate and butanoate metabolism pathways, and correlation analyses revealed close relationships among microbiota, SCFAs, and muscle parameters. Collectively, these data suggest a potential mechanism whereby composite dietary fiber counteracts muscle atrophy in obesity by modulating the gut microbiota to increase SCFA production and downregulate proteolytic signaling, implicating its potential as a dietary intervention for muscle metabolic disorders.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.